BSE SENSEX S&P CNX 19,016 5,783 Bloomberg BRIT IN Equity Shares (m) 119.5 M.Cap. (INR b)/(usd b) 65.2/1.2 52-Week Range (INR) 595/400 1,6,12 Rel. Perf. (%) 3/10/-13 Financials & Valuation (INR b) Y/E March 2013E 2014E 2015E Sales 55.4 64.7 75.5 EBITDA 2.8 3.6 4.4 Adj. PAT 2.1 2.5 3.0 Adj. EPS (INR) 17.2 21.3 25.2 EPS Gr. (%) 9.8 23.8 18.5 BV/Sh.(INR) 51.3 60.2 70.8 RoE (%) 33.5 35.3 35.6 RoCE (%) 54.3 53.9 50.8 Payout (%) 45.6 50.0 50.0 Valuations P/E (x) 30.3 24.5 20.6 P/BV (x) 10.1 8.6 7.3 EV/EBITDA (x) 21.5 16.3 13.3 Div. Yield (%) 1.5 2.0 2.4 Shareholding pattern (%) As on Mar-13 Dec-12 Mar-12 Promoter 50.9 50.9 51.0 Dom. Inst 11.3 13.0 16.2 Foreign 17.9 15.7 13.6 Others 19.9 20.3 19.2 Stock performance (1 year) 22 April 2013 Update Sector: Consumer CMP: INR546 TP: INR605 Upgrade to Neutral Volume growth bottoms out; Upgrade to Neutral Premiumization strategy yielding benefits; non-biscuits margins improving Volume growth has bottomed out and should benefit from a favorable base ahead. Benefits of premiumization are reflecting in the margins despite higher input costs. See scope for re-rating as volume improves and margins expand 80bp over FY13E-15E. Upgrade to Neutral with a target price of INR605, a potential upside of 11%. Biscuits volume growth has likely bottomed out We believe Britannia's (BRIT) volume growth in its core biscuits category has bottomed out and will benefit from the favorable base effect, going forward. Though the processed foods segment is undergoing a slowdown, BRIT's consistent investments in the category should stand it in good stead, in our view. We expect it to post 8% volume growth in biscuits in FY14E, driven by premium portfolio. Premiumization strategy yields dividend; Glucose salience declines BRIT has focused to drive the premiumization strategy, given the business' low margin nature and inflationary trend in its RM basket. Company consistently innovated its portfolio and expanded the offerings in Health, Cookies and Creams segment, where the realization is 2-4x base variants. Thus, it managed to expand the gross margin by 150bp in 9MFY13, despite sharp input cost inflation. We expect BRIT to continue to expand its premium portfolio, in line with the broader category trend where contribution of Glucose is declining. We note the Glucose category has declined 4.5%, while Creams and Cookies segment has grown 21.8% and 5.5% respectively over CY10-12, as per industry data. Non-biscuits portfolio gains strength; Subsidiaries turning profitable BRIT's non-biscuits portfolio (Bread, Cake, Rusk, Dairy and International) is gaining size and is now an INR15b business on an annualized basis. Pertinently, profitability of international subsidiary and dairy subsidiary has been improving consistently since FY09. As these businesses gain size, operating leverage can provide margin upside, in our view. Underperformance discounts negatives; Worst is over; Upgrade to Neutral BRIT has underperformed the BSE FMCG index by 32%/20% in last 12/24 months due to deceleration in Biscuits volume and subdued profit growth. Going forward, we expect a volume recovery; with higher input costs in the base, margins should expand given the premiumization led by mix improvement. We estimate 21% earnings CAGR for FY13E-15E led by 16.5% sales growth and 80bp operating margin expansion to 5.8%. Given our expected improvement in operational performance, we believe valuations at 24.5x FY14E and 20.6x FY15E have a scope for re-rating, albeit modest. We value BRIT at 24x FY15E, peg the target price at INR605, an upside of 11%, and upgrade to Neutral. Spike in input costs and any adverse changes in premiumization trend are the key risks. 22 April 2013 1
Biscuits volume growth bottoms out...disproportionate investments to drive premium portfolio mix Biscuits volume growth has decelerated for last six-seven quarters. Expect favorable base to aid volume growth ahead despite processed foods slowdown. Britannia's consistent investments to drive premiumization in portfolio. After decelerating for six to seven successive quarters, Biscuits volume growth recovered in 3QFY13 at ~5.5%. We expect this recovery to sustain partially aided by a favorable base effect. Notwithstanding the overall slowdown in processed foods segment, we believe BRIT's consistent and disproportionate focus to drive innovation and premiumization will cushion the volume. Volume growth to benefit from favorable base......and aggressive investments to drive premiumization Source: Company, MOSL Given that less than 9% of the Foods category is branded, management believes there is significant room for growth. Biscuits, despite being one of the largest processed foods category at USD2.2b and well penetrated, offer good opportunity as per capita consumption at 2kg in India is half of a Sri Lanka. Biscuits is the largest category in processed foods has posted 8% volume CAGR over CY10-12 Source: Industry, MOSL 22 April 2013 2
Realization rose due to RM inflation Key category growth indicators Source: Industry, MOSL 22 April 2013 3
Premiumization strategy yields dividend...industry data validates the underlying trend Britannia has focussed on driving premiumization given the RM inflation trends. Industry data confirms the underlying premiumization trend in the category. Glucose category salience for the industry has been declining consistently. BRIT has focused on the premiumization strategy given the low margin nature of business and inflationary trend in its RM basket. It consistently innovated the portfolio and expanded offerings in the Health, Cookies and Creams segment, where the realization is 2-4x base variants. We believe the Biscuits industry data for CY10-12 vindicates the underlying premiumization trend in the category. Following section explains the story in charts: While the Biscuits industry posted 8% volume CAGR Glucose category declined 4.5% in volumes Contribution of Glucose category declines BRIT has lost share in Glucose category Source: Industry, MOSL 22 April 2013 4
so has ITC while Parle has gained Even in CY12 Glucose underperformed other categories in volume and value terms Source: Industry, MOSL 22 April 2013 5
BRIT's premium portfolio has done well aiding gross profitability Premium portfolio has outperformed for Britannia Innovation sales index has gone up 2.5x since FY11. Britannia has expanded its health based offerings in the last 18 months. BRIT's premium portfolio (Marie Gold, 50-50, Nutrichoice, Treat etc) has outperformed the category growth and provided support to profitability. We note the innovation sales index has risen ~2.5x since FY11. BRIT's premium portfolio has done well... Innovation sales index up ~2.5x Source: Company, MOSL BRIT's premiumization efforts: moving up the value chain Good-Day Regular Good-Day Chocochip Good-Day Fresh Bake 50-50 Regular 50-50 Maska Chaska 50-50 Snackuits Nutrichoice Digestive Nutrichoice Oats Nutrichoice Multigrain Thins 22 April 2013 6
Company kept the innovation engine running and consistently unveiled new variants. According to management, BRIT enjoys 4x relative market share of its next competitor in health-focused biscuits (Nutrichoice) and is neck to neck with ITC in the premium cream segment. BRIT has clearly targeted the health and wellness plank with several launches in the space across categories - Nutrichoice Biscuits, Multigrain Breads, Slimz Milk and Cheese Slices (extra calcium). BRIT's recent innovations in Biscuits and other categories; Leveraging the health platform Premiumization strategy yields results; Gross margin up 150bp in 9MFY13 Company's premiumization strategy has started bearing fruits and is reflected in margins. Gross margin for 9MFY13 improved 150bp YoY to 36.7% after having already expanded 150bp in FY12 v/s FY11. For the quarter-ended December 2012, 18% sales growth was driven by a combination of 5.5% pricing, 6% volume and ~6% mix gains. Expect operating margin expansion of 80bps over FY13-15e...lead by improved gross margins due to lower RM inflation Source: Company, MOSL 22 April 2013 7
Margin expansion despite sharp input cost inflation Gross margin expanded despite the sharp inflation in key raw materials - average wheat and sugar costs were up 21.7% and 13.8% respectively in FY13. The adverse impact of higher input costs was mitigated by a combination of price hikes, grammage change and mix improvement, in our view. Wheat and sugar price inflation resulted in incremental INR1.8b impact during 9MFY13. Rising diesel prices will lead to incremental cost of INR15m per month. However, prices of vegetable oil and skimmed milk powder have corrected. In our view, being a category with low operating margin and high competitive intensity, the only option to maintain profitability in the long term is through mix improvement in favor of niche offerings, which allows certain pricing power to the brand manufacturer. As mentioned earlier, the industry is moving towards premium segments in both urban and rural markets. Despite the gross margin expansion, operating margin declined 50bp YoY in 9MFY13 due to higher advertising spends to support new launches. Conversion costs rose 70bp. BRIT has undertaken several cost rationalization initiatives in the back-end to drive margin savings. It is setting up a new plant in Gujarat at Jhagadia to reduce the freight cost and is also undertaking process improvement in production through various measures - TQM, TPM, Kaizen etc. Wheat prices adversely impacted in FY13; down 12% from peak......sugar prices down 15% from peak Source: Bloomberg, MOSL SMP prices have remained flat Palm oil is down 30% YoY but up 10% from the low Source: Bloomberg, MOSL 22 April 2013 8
Non-Biscuits portfolio gains in size and accretive to bottom line... International subsidiaries profitability improves Non-Biscuits is now tracking annual INR15b revenue. Profiability is consistently improving for all international subsidiaries. Expect operating leverage to play out. BRIT's non-biscuits portfolio Dairy, Cake, Rusk, Bakery is gaining in size led by portfolio expansion and differentiated offerings. Non-Biscuits coupled with International business is now an INR15b business on an annualized basis. Profitability in these businesses is on an improving trend and we expect the operating leverage to materialize, going forward. Robust sales growth in FY12 for non-biscuits portfolio PAT margin improves consistently PAT margin improves across subsidiaries even in International business (Al-Sallan + Strategic Foods Int) *We have considered four key subsidiaries - Dairy Products, Daily Bread, Strategic Foods, Al-Sallan. Source: Company, MOSL 22 April 2013 9
Underperformance discounts negatives Worst is over; Upgrade to Neutral BRIT has underperformed the FMCG index by 32% in 12 months - second worst performing stock in our FMCG universe. Expect valuations to undergo modest re-rating as operational performance improves in FY14E and FY15E. Ugrading to Neutral with INR605 target price, 11% upside. BRIT has underperformed the BSE FMCG index by 32%/20% in last 12/24 months due to deceleration in Biscuits volume and subdued profit growth. On a 12-month basis, it has been the second worst performing stock in our FMCG universe relative to the BSE FMCG index. Going forward, we expect a volume recovery; with higher input costs in the base, margins should expand given the premiumization led by mix improvement. We estimate 21% earnings CAGR for FY13E-15E led by 16.5% sales growth and 80bp operating margin expansion to 5.8%. Given our expected improvement in operational performance, we believe valuations at 24.5x FY14E and 20.6x FY15E have a scope for re-rating, albeit modest. We value BRIT at 24x FY15E, peg the target price at INR605, an upside of 11%, and upgrade to Neutral. Spike in input costs and any adverse changes in premiumization trend are the key risks. Underperformed BSE FMCG index by 40% in a year and Sensex by 13% over 1 year (outperformed over 2 years) P/E chart P/B chart Source: Bloomberg, MOSL 22 April 2013 10
BRIT is the worst performing stock in our FMCG universe in 12-month period Absolute Performance (%) Relative Performance to BSE FMCG(%) Company 3 M 6M 1 Yr 2 Yr 3 M 6M 1 Yr 2 Yr Asian Paints 7.9 18.5 40.4 80.4 1.9 14.3 12.1 15.5 Britannia Inds. 12.2 11.3-4.1 44.8 6.3 7.1-32.4-20.1 Colgate-Palm. -7.4 11.3 22.1 56.9-13.3 7.1-6.2-8.0 Nestle India -2.9-1.4-6.0 24.9-8.8-5.6-34.3-40.1 GlaxoSmith C H L 2.9 29.6 37.7 71.7-3.0 25.4 9.4 6.8 Hind. Unilever -1.4-16.1 14.2 72.3-7.4-20.3-14.1 7.4 ITC 9.8 8.2 30.4 66.0 3.9 4.0 2.2 1.1 Dabur India 9.8 7.3 27.5 37.2 3.9 3.1-0.7-27.7 Marico -4.8 3.5 18.4 55.9-10.8-0.7-9.9-9.0 Godrej Consumer 7.6 13.9 51.4 102.7 1.7 9.7 23.2 37.8 BSE FMCG 5.9 4.2 28.3 64.9 22 April 2013 11
Financials and Valuation Income Statement (INR Million) Y/E March 2011 2012 2013E 2014E 2015E Net Revenues 41,983 49,470 55,396 64,691 75,451 Change (%) 23.4 17.8 12.0 16.8 16.6 Raw Material Cost 27,643 31,798 35,017 40,598 47,066 Gross Profit 14,340 17,673 20,379 24,093 28,385 Margin (%) 34.2 35.7 36.8 37.2 37.6 Advertising 3,042 3,810 4,819 5,628 6,564 % of Sales 7.2 7.7 8.7 8.7 8.7 Other Expenditure 9,236 11,343 12,769 14,823 17,422 EBITDA 2,063 2,521 2,790 3,642 4,399 Change (%) 35.4 33.2 10.7 30.5 20.8 Margin (%) 4.9 5.1 5.0 5.6 5.8 Depreciation 446 473 547 636 723 Int. and Fin. Charges 378 381 366 113 142 Financial Other Income 489 585 587 580 600 Operating Other Income 252 272 350 174 189 PBT 1,981 2,524 2,814 3,646 4,323 Change (%) 15.4 27.4 11.5 29.6 18.6 Margin (%) 4.7 5.1 5.1 5.6 5.7 Tax 528 656 790 1,146 1,357 Deferred Tax 0 0-26 -38-43 Tax Rate (%) 26.6 26.0 27.1 30.4 30.4 PAT 1,453 1,867 2,051 2,538 3,009 Change (%) -13.2 28.5 9.8 23.8 18.5 Margin (%) 3.5 3.8 3.7 3.9 4.0 Reported PAT 1,453 1,867 2,051 2,538 3,008 Balance Sheet (INR Million) Y/E March 2011 2012 2013E 2014E 2015E Share Capital 239 239 239 239 239 Reserves 4,274 5,108 5,892 6,955 8,215 Networth 4,513 5,347 6,131 7,194 8,454 Loans 4,607 4,326 811 851 1,509 Capital Employed 9,120 9,674 6,942 8,045 9,963 Gross Block 5,936 6,386 7,636 8,886 10,136 Less: Accum. Depn. -2,899-3,379-3,926-4,562-5,285 Net Fixed Assets 3,037 3,007 3,710 4,324 4,851 Capital WIP 117 1,000 250 250 250 Investments 5,450 5,264 1,960 2,309 3,721 Deferred Liability -62 10 37 75 118 Currents Assets 6,254 7,387 8,469 9,978 11,500 Inventory 3,112 3,741 4,155 5,175 6,036 Account Receivables 573 690 794 958 1,116 Cash and Bank Balance 287 614 1,062 1,219 1,557 Others 2,282 2,343 2,459 2,626 2,791 Curr. Liab. & Prov. 5,676 6,995 7,484 8,890 10,477 Account Payables 3,329 4,560 5,026 5,840 6,978 Other Liabilities 1,073 1,073 1,175 1,288 1,412 Provisions 1,274 1,362 1,283 1,761 2,087 Net Current Assets 578 393 985 1,088 1,023 Net Assets 9,120 9,674 6,942 8,045 9,963 E: MOSL Estimates 22 April 2013 12
Financials and Valuation Ratios Y/E March 2011 2012 2013E 2014E 2015E Basic (INR) EPS 12.2 15.6 17.2 21.3 25.2 BV/Share 37.8 44.8 51.3 60.2 70.8 DPS 6.5 8.5 7.8 10.6 12.6 Payout (%) 53.4 54.4 45.6 50.0 50.0 Valuation (x) P/E 33.3 30.3 24.5 20.6 EV/Sales 1.2 1.1 0.9 0.8 EV/EBITDA 24.0 21.5 16.3 13.3 P/BV 11.6 10.1 8.6 7.3 Dividend Yield 1.6 1.5 2.0 2.4 Return Ratios (%) RoE 32.2 34.9 33.5 35.3 35.6 RoCE 31.2 36.1 54.3 53.9 50.8 Working Capital Ratios Debtor (Days) 5 5 5 5 5 Asset Turnover (x) 4.6 5.1 8.0 8.0 7.6 Leverage Ratio Debt/Equity (x) 1.0 0.8 0.1 0.1 0.2 Cash Flow Statement (INR Million) Y/E March 2011 2012 2013E 2014E 2015E OP Profit 2,063 2,521 2,790 3,642 4,399 Financial Other Income 489 585 587 580 600 Interest Paid 378 381 366 113 142 Direct Taxes Paid 528 656 790 1,146 1,357 Inc in WC 121-512 144-53 -403 CF from Operations 1,526 2,581 2,077 3,016 3,903 Extraordinary Items (Inc)/Dec in FA 475 1,333 500 1,250 1,250 (Pur.)/Sale of Investments 544-186 -3,304 348 1,413 Other Non Rec Exp 0 0 0 0 1 CF from Investments 1,018 1,147-2,804 1,598 2,664 Inc in Debt 279-281 -3,515 40 658 Dividend Paid 696 902 1,157 1,086 1,475 Other Item 36-76 -233 215 84 CF from Fin. Activity -454-1,107-4,439-1,261-901 Inc/Dec of Cash 54 327 442 157 338 Add: Beginning Balance 234 287 614 1,062 1,219 Closing Balance 288 614 1,056 1,219 1,557 E: MOSL Estimates 22 April 2013 13
Disclosures This report is for personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This report is intended for distribution to institutional investors. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement 1. Analyst ownership of the stock No 2. Group/Directors ownership of the stock No 3. Broking relationship with company covered No 4. Investment Banking relationship with company covered No Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons. For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Nihar Oza Kadambari Balachandran Email: niharoza.sg@motilaloswal.com Email : kadambari.balachandran@motilaloswal.com Contact: (+65) 68189232 Contact: (+65) 68189233 / 65249115 Office address: 21 (Suite 31), 16 Collyer Quay, Singapore 049318 Motilal Oswal Securities Ltd Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai 400 025 Phone: +91 22 3982 5500 E-mail: reports@motilaloswal.com